At a time when the nation faces significant public health challenges, strong scientific leadership at the CDC is essential. Dr. Erica Schwartz brings an impressive combination of clinical expertise, public health experience, and proven leadership.
For the first time in its history, AAI is proud to endorse a state-level ballot initiative. If approved by voters…
AAI has announced its support for the California Immunology Medical Research & Cures Initiative, a historic statewide ballot measure that would invest $8.4 billion in cutting-edge immunology research in California if approved by voters this November.
AAI to Respond, Urges Responses by Individual Researchers On May 29, the White House Office of Management and Budget (OMB)…
Ulrich H. von Andrian, MD, President of the American Association of Immunologists (AAI), responds to the House Appropriations Committee’s markup…
On May 26, AAI submitted comments in response to the National Institutes of Health (NIH) Request for Information (RFI) on…
Last month, Cherry Cheung, PhD, a member of the 2025–26 cohort of the AAI Public Policy Fellows Program (PPFP), organized…
Experts discussed the state of U.S. vaccine policy and the role of scientists and professional societies in moving forward.
AAI is deeply alarmed by the Administration’s fiscal year (FY) 2027 budget request, which calls for an estimated $5.8 billion reduction in funding for NIH compared with FY 2026.
AAI is delighted to announce the sixteenth class of AAI Public Policy Fellows, who officially begin their one-year fellowship on May 1….
